Prelude Therapeutics Incorporat - stock earnings
PRLD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -33.1 million USD | ? USD |
| 2023Q3 | -30.6 million USD | ? USD |
| 2023Q2 | -30.4 million USD | ? USD |
| 2023Q1 | -26.3 million USD | ? USD |
| 2022Q4 | -21.0 million USD | ? USD |
| 2022Q3 | -29.5 million USD | ? USD |
| 2022Q2 | -25.3 million USD | ? USD |
| 2022Q1 | -28.6 million USD | ? USD |
| 2021Q4 | -32.8 million USD | ? USD |
| 2021Q3 | -30.7 million USD | ? USD |
| 2021Q2 | -26.9 million USD | ? USD |
| 2021Q1 | -21.3 million USD | ? USD |
| 2020Q4 | -19.3 million USD | ? USD |
| 2020Q3 | -16.8 million USD | ? USD |
| 2020Q2 | -11.4 million USD | ? USD |
| 2020Q1 | -9.5 million USD | ? USD |
| 2019Q4 | -10.0 million USD | ? USD |
| 2019Q3 | -6.7 million USD | ? USD |
PRLD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -121.8 million USD | ? USD |
| 2022 | -107.3 million USD | ? USD |
| 2021 | -110.8 million USD | ? USD |
| 2020 | -56.9 million USD | ? USD |
| 2019 | -27.6 million USD | ? USD |
| 2018 | -14.7 million USD | ? USD |
PRLD
Price: $4.07
52 week price:
Earnings Per Share: -2.02 USD
P/E Ratio: -1.37
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 65500
Market Capitalization: 286.7 million